BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 25740667)

  • 1. Does vitamin D mediate inhibition of epithelial ovarian cancer by modulating cytokines?
    Mohapatra S; Saxena A; Gandhi G; Koner BC; Singh T; Ray PC
    Clin Transl Oncol; 2015 Aug; 17(8):590-5. PubMed ID: 25740667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of the balance between type 1 and type 2 T helper cells on ovarian cancer.
    Hao CJ; Li J; Liu P; Li XL; Hu YQ; Sun JC; Wei Y
    Genet Mol Res; 2016 Jun; 15(2):. PubMed ID: 27323126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relative expression levels of Th1 and Th2 cytokine mRNA are independent prognostic factors in patients with ovarian cancer.
    Kusuda T; Shigemasa K; Arihiro K; Fujii T; Nagai N; Ohama K
    Oncol Rep; 2005 Jun; 13(6):1153-8. PubMed ID: 15870936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune response evaluation through determination of type 1, type 2, and type 17 patterns in patients with epithelial ovarian cancer.
    Cândido EB; Silva LM; Carvalho AT; Lamaita RM; Filho RM; Cota BD; da Silva-Filho AL
    Reprod Sci; 2013 Jul; 20(7):828-37. PubMed ID: 23239818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low 25-OH vitamin D levels at time of diagnosis and recurrence of ovarian cancer.
    Granato T; Manganaro L; Petri L; Porpora MG; Viggiani V; Angeloni A; Anastasi E
    Tumour Biol; 2016 Feb; 37(2):2177-81. PubMed ID: 26349750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pre-diagnostic serum levels of inflammation markers and risk of ovarian cancer in the prostate, lung, colorectal and ovarian cancer (PLCO) screening trial.
    Trabert B; Pinto L; Hartge P; Kemp T; Black A; Sherman ME; Brinton LA; Pfeiffer RM; Shiels MS; Chaturvedi AK; Hildesheim A; Wentzensen N
    Gynecol Oncol; 2014 Nov; 135(2):297-304. PubMed ID: 25158036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinicopathologic and prognostic significance of serum levels of cytokines in patients with advanced serous ovarian cancer prior to surgery].
    Zhu X; Ying LS; Xu SH; Zhu CH; Xie JB
    Zhonghua Bing Li Xue Za Zhi; 2010 Oct; 39(10):666-70. PubMed ID: 21176531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of Th1/Th2 cytokines in the diagnosis and prognostic evaluation of ankylosing spondylitis.
    Wen JT; Zhang DH; Fang PF; Li MH; Wang RJ; Li SH
    Genet Mol Res; 2017 Mar; 16(1):. PubMed ID: 28362980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated Th22 cells and related cytokines in patients with epithelial ovarian cancer.
    Wang T; Zhang Z; Xing H; Wang L; Zhang G; Yu N; Wang J; Guo W; Jiang J
    Medicine (Baltimore); 2017 Oct; 96(43):e8359. PubMed ID: 29069020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Serum cytokines in patients with ovarian cancer and benign ovarian cysts].
    Nowak M; Szpakowski M; Malinowski A; Wieczorek A; Maciołek-Blewniewska G; Wilczyński JR; Szpakowski A; Wierzbicka E; Małafiej E; Oszukowski P
    Ginekol Pol; 2001 Dec; 72(12A):1444-8. PubMed ID: 11883294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. KPNA2 is a potential diagnostic serum biomarker for epithelial ovarian cancer and correlates with poor prognosis.
    Huang L; Zhou Y; Cao XP; Lin JX; Zhang L; Huang ST; Zheng M
    Tumour Biol; 2017 Jun; 39(6):1010428317706289. PubMed ID: 28651492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Detection of serum Th1 and Th2 cytokines and its significance in neonates with cytomegalovirus pneumonia].
    Chen ZG; Ji JZ; Li M; Chen YF; Chen FH; Chen H; Bu J; Sun JH
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Dec; 21(4):361-3. PubMed ID: 18322603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of serum interleukin-18 level as a prognostic indicator in patients with epithelial ovarian carcinoma.
    Akahiro J; Konno R; Ito K; Okamura K; Yaegashi N
    Int J Clin Oncol; 2004 Feb; 9(1):42-6. PubMed ID: 15162825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative angiopoietin-2 serum levels: a marker of malignant potential in ovarian neoplasms and poor prognosis in epithelial ovarian cancer.
    Sallinen H; Heikura T; Laidinen S; Kosma VM; Heinonen S; Ylä-Herttuala S; Anttila M
    Int J Gynecol Cancer; 2010 Dec; 20(9):1498-505. PubMed ID: 21119365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ovarian cancer-induced immunosuppression: relationship to tumor necrosis factor-alpha (TNF-alpha) release from ovarian tissue.
    Hassan MI; Kassim SK; Saeda L; Laban M; Khalifa A
    Anticancer Res; 1999; 19(6C):5657-62. PubMed ID: 10697636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating levels of TNF-alpha and its soluble receptors in the plasma of patients with epithelial ovarian cancer.
    Dobrzycka B; Terlikowski SJ; Kowalczuk O; Kinalski M
    Eur Cytokine Netw; 2009 Sep; 20(3):131-4. PubMed ID: 19825522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum levels of IL-6, IL-8 and CRP as prognostic factors in epithelial ovarian cancer.
    Dobrzycka B; Mackowiak-Matejczyk B; Terlikowska KM; Kulesza-Bronczyk B; Kinalski M; Terlikowski SJ
    Eur Cytokine Netw; 2013; 24(3):106-13. PubMed ID: 24197277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Quantitative and functional changes of T helper cell subsets in the bone marrow of severe aplastic anemia patients].
    He GS; Shao ZH; He H; Liu H; Bai J; Shi J; Cao YR; Tu MF; Sun J; Jia HR; Yang CL
    Zhonghua Xue Ye Xue Za Zhi; 2004 Oct; 25(10):613-6. PubMed ID: 15634596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical significance of serum Th1-, Th2- and regulatory T cells-associated cytokines in adult T-cell leukemia/lymphoma: high interleukin-5 and -10 levels are significant unfavorable prognostic factors.
    Inagaki A; Ishida T; Ishii T; Komatsu H; Iida S; Ding J; Yonekura K; Takeuchi S; Takatsuka Y; Utsunomiya A; Ueda R
    Int J Cancer; 2006 Jun; 118(12):3054-61. PubMed ID: 16425276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating inflammation markers and risk of epithelial ovarian cancer.
    Clendenen TV; Lundin E; Zeleniuch-Jacquotte A; Koenig KL; Berrino F; Lukanova A; Lokshin AE; Idahl A; Ohlson N; Hallmans G; Krogh V; Sieri S; Muti P; Marrangoni A; Nolen BM; Liu M; Shore RE; Arslan AA
    Cancer Epidemiol Biomarkers Prev; 2011 May; 20(5):799-810. PubMed ID: 21467242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.